glp-1 receptor agonist brands list Market Overview: Agonists and the Obesity Market | Blog GLP-1 Drug Savings: A Complete
Description
Jackson C et al, Applying COM-B to medication adherence: A suggested framework for research and interventions
Min JS, Bae SK
We were doing studies, but we had a problem
Unfortunately, if these medications are stopped, patients regain almost 70% of their lost weight on average within one year
The discussion of how long to stay on semaglutide is also relevant for people planning their protocol duration in the context of employment or health monitoring timelines
2025 Jan;35(1):69-78
